Christopher Kurz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher Kurz has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Florian Kamp
Department of Radiation Oncology, LMU Munich, University Hospital, Munich, GERMANY
8 shared publicationsKatia Parodi
Department of Medical Physics, Ludwig-Maximilians-Universität München Fakultät für Physik, München, Bayern, GERMANY
8 shared publicationsClaus Belka
Department of Radiation Oncology, LMU Munich, University Hospital, Munich, GERMANY
7 shared publicationsGuillaume Landry
Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München, Am Coulombwall 1, 85748 Garching bei München, Germany
6 shared publicationsMinglun Li
Department of Radiation Oncology, LMU Munich, University Hospital, Munich, GERMANY
4 shared publications- Ute Ganswindt
Department of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria
4 shared publications
Latest Publications
- 1 November 2019
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 64 (22) , 225004
CBCT correction using a cycle-consistent generative adversarial network and unpaired training to enable photon and proton dose calculation
In presence of inter-fractional anatomical changes, clinical benefits are anticipated from image-guided adaptive radiotherapy. Nowadays, cone-beam CT (CBCT) imaging is mostly utilized during pre-treatment imaging for position verification. Due to various artifacts, image quality is typically not sufficient for photon or proton dose calculation, thus demanding accurate CBCT correction, as potentially provided by deep learning techniques. This work aimed at investigating the feasibility of utilizing a cycle-consistent generative adversarial network (cycleGAN) for prostate CBCT correction using unpaired training. Thirty-three patients were included. The network was trained to translate uncorrected, original CBCT images (CBCT org ) into planning CT equivalent images (CBCT cycleGAN ). HU accuracy was determined by comparison to a previously validated CBCT correction technique (CBCT cor ). Dosimetric accuracy was inferred for volumetric-modulated arc photon therapy (VMAT) and opposing single-field uniform dose (OSFUD) proton plans, optimized on CBCT cor and recalculated on CBCT cycleGAN . Single-sided SFUD proton plans were utilized to assess proton range accuracy. The mean HU error of CBCT cycleGAN with respect to CBCT cor decreased from 24 HU for CBCT org to −6 HU. Dose calculation accuracy was high for VMAT, with average pass-rates of 100%/89% for a 2%/1% dose difference criterion. For proton OSFUD plans, the average pass-rate for a 2% dose difference criterion was 80%. Using a (2%, 2 mm) gamma criterion, the pass-rate was 96%. 93% of all analyzed SFUD profiles had a range agreement better than 3 mm. CBCT correction time was reduced from 6–10 min for CBCT cor to 10 s for CBCT cycleGAN . Our study demonstrated the feasibility of utilizing a cycleGAN for CBCT correction, achieving high dose calculation accuracy for VMAT. For proton therapy, further improvements may be required. Due to unpaired training, the approach does not rely on anatomically consistent training data or potentially inaccurate deformable image registration. The substantial speed-up for CBCT correction renders the method particularly interesting for adaptive radiotherapy.
- 1 November 2019
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 64 (22) , 225004
CBCT correction using a cycle-consistent generative adversarial network and unpaired training to enable photon and proton dose calculation
In presence of inter-fractional anatomical changes, clinical benefits are anticipated from image-guided adaptive radiotherapy. Nowadays, cone-beam CT (CBCT) imaging is mostly utilized during pre-treatment imaging for position verification. Due to various artifacts, image quality is typically not sufficient for photon or proton dose calculation, thus demanding accurate CBCT correction, as potentially provided by deep learning techniques. This work aimed at investigating the feasibility of utilizing a cycle-consistent generative adversarial network (cycleGAN) for prostate CBCT correction using unpaired training. Thirty-three patients were included. The network was trained to translate uncorrected, original CBCT images (CBCT org ) into planning CT equivalent images (CBCT cycleGAN ). HU accuracy was determined by comparison to a previously validated CBCT correction technique (CBCT cor ). Dosimetric accuracy was inferred for volumetric-modulated arc photon therapy (VMAT) and opposing single-field uniform dose (OSFUD) proton plans, optimized on CBCT cor and recalculated on CBCT cycleGAN . Single-sided SFUD proton plans were utilized to assess proton range accuracy. The mean HU error of CBCT cycleGAN with respect to CBCT cor decreased from 24 HU for CBCT org to −6 HU. Dose calculation accuracy was high for VMAT, with average pass-rates of 100%/89% for a 2%/1% dose difference criterion. For proton OSFUD plans, the average pass-rate for a 2% dose difference criterion was 80%. Using a (2%, 2 mm) gamma criterion, the pass-rate was 96%. 93% of all analyzed SFUD profiles had a range agreement better than 3 mm. CBCT correction time was reduced from 6–10 min for CBCT cor to 10 s for CBCT cycleGAN . Our study demonstrated the feasibility of utilizing a cycleGAN for CBCT correction, achieving high dose calculation accuracy for VMAT. For proton therapy, further improvements may be required. Due to unpaired training, the approach does not rely on anatomically consistent training data or potentially inaccurate deformable image registration. The substantial speed-up for CBCT correction renders the method particularly interesting for adaptive radiotherapy.
- 1 August 2019
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 29 (3) , 216-228
Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization
- 1 August 2019
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 29 (3) , 216-228
Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization
- 8 October 2018
- Published by Wiley in Medical Physics
- Vol. 45 (11) , 4916-4926
ScatterNet: A convolutional neural network for cone‐beam CT intensity correction
Purpose: To demonstrate a proof‐of‐concept for fast cone‐beam CT (CBCT) intensity correction in projection space by the use of deep learning.Methods: The CBCT scans and corresponding projections were acquired from 30 prostate cancer patients. Reference shading correction was performed using a validated method (CBCT), which estimates scatter and other low‐frequency deviations in the measured CBCT projections on the basis of a prior CT image obtained from warping the planning CT to the CBCT. A convolutional neural network (ScatterNet) was designed, consisting of an attenuation conversion stage followed by a shading correction stage using a UNet‐like architecture. The combined network was trained in 2D, utilizing pairs of measured and corrected projections of the reference method, in order to perform shading correction in projection space before reconstruction. The number of patients used for training, testing, and evaluation was 15, 7, and 8, respectively. The reconstructed CBCT was compared to CBCT in terms of mean and absolute errors (ME and MAE) for the eight evaluation patients (not included in the network training). Volumetric modulated arc photon therapy (VMAT) and intensity‐modulated proton therapy (IMPT) plans were generated on CBCT. Dose was recalculated on CBCT to evaluate its dosimetric accuracy. Single‐field uniform dose proton plans were utilized for proton range comparison of CBCT and CBCT.Results: The CBCT showed no cupping artifacts and a considerably smaller MAE and ME with respect to CBCT than the uncorrected CBCT (on average 144 Hounsfield units (HU) vs 46 HU for MAE and 138 HU vs −3 HU for ME). The pass‐rates using a 2% dose‐difference criterion at 50% dose cut‐off, were close to 100% for the VMAT plans of all patients when comparing CBCT to CBCT. For IMPT plans pass‐rates were clearly lower, ranging from 15% to 81%. Proton range differences of up to 5 mm occurred.Conclusions: Using a deep convolutional neural network for CBCT intensity correction was shown to be feasible in the pelvic region for the first time. Dose calculation accuracy on CBCT was high for VMAT, but unsatisfactory for IMPT. With respect to the reference technique (CBCT), the neural network enabled a considerable increase in speed for intensity correction and might eventually allow for on‐the‐fly shading correction during CBCT acquisition.
- 8 October 2018
- Published by Wiley in Medical Physics
- Vol. 45 (11) , 4916-4926
ScatterNet: A convolutional neural network for cone‐beam CT intensity correction
Purpose: To demonstrate a proof‐of‐concept for fast cone‐beam CT (CBCT) intensity correction in projection space by the use of deep learning.Methods: The CBCT scans and corresponding projections were acquired from 30 prostate cancer patients. Reference shading correction was performed using a validated method (CBCT), which estimates scatter and other low‐frequency deviations in the measured CBCT projections on the basis of a prior CT image obtained from warping the planning CT to the CBCT. A convolutional neural network (ScatterNet) was designed, consisting of an attenuation conversion stage followed by a shading correction stage using a UNet‐like architecture. The combined network was trained in 2D, utilizing pairs of measured and corrected projections of the reference method, in order to perform shading correction in projection space before reconstruction. The number of patients used for training, testing, and evaluation was 15, 7, and 8, respectively. The reconstructed CBCT was compared to CBCT in terms of mean and absolute errors (ME and MAE) for the eight evaluation patients (not included in the network training). Volumetric modulated arc photon therapy (VMAT) and intensity‐modulated proton therapy (IMPT) plans were generated on CBCT. Dose was recalculated on CBCT to evaluate its dosimetric accuracy. Single‐field uniform dose proton plans were utilized for proton range comparison of CBCT and CBCT.Results: The CBCT showed no cupping artifacts and a considerably smaller MAE and ME with respect to CBCT than the uncorrected CBCT (on average 144 Hounsfield units (HU) vs 46 HU for MAE and 138 HU vs −3 HU for ME). The pass‐rates using a 2% dose‐difference criterion at 50% dose cut‐off, were close to 100% for the VMAT plans of all patients when comparing CBCT to CBCT. For IMPT plans pass‐rates were clearly lower, ranging from 15% to 81%. Proton range differences of up to 5 mm occurred.Conclusions: Using a deep convolutional neural network for CBCT intensity correction was shown to be feasible in the pelvic region for the first time. Dose calculation accuracy on CBCT was high for VMAT, but unsatisfactory for IMPT. With respect to the reference technique (CBCT), the neural network enabled a considerable increase in speed for intensity correction and might eventually allow for on‐the‐fly shading correction during CBCT acquisition.
- 1 August 2018
- Published by Elsevier in Physica Medica
- Vol. 52, 36-37
[I093] Mr-guided radiotherapy at the LMU in Munich: Preliminary studies
- 1 August 2018
- Published by Elsevier in Physica Medica
- Vol. 52, 36-37
[I093] Mr-guided radiotherapy at the LMU in Munich: Preliminary studies
- 19 October 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (21) , 8470-8482
A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer
Combining magnetic-resonance imaging (MRI) and proton therapy (PT) using pencil-beam scanning (PBS) may improve image-guided radiotherapy. We aimed at assessing the impact of a magnetic field on PBS-PT plan quality and robustness. Specifically, the robustness against anatomical changes and positioning errors in an MRI-guided scenario with a 30 cm radius 1.5 T magnetic field was studied for prostate PT. Five prostate cancer patients with three consecutive CT images ( CT1-3 ) were considered. Single-field uniform dose PBS-PT plans were generated on the segmented CT1 with Monte-Carlo-based treatment planning software for inverse optimization. Plans were optimized at 90° gantry angle without B-field ( no B ), with ±1.5 T B-field ( B and minus B ), as well as at 81° gantry angle and +1.5 T ( B G81 ). Plans were re-calculated on aligned CT2 and CT3 to study the impact of anatomical changes. Dose distributions were compared in terms of changes in DVH parameters, proton range and gamma-index pass-rates. To assess the impact of positioning errors, DVH parameters were compared for ±5 mm CT1 patient shifts in anterior–posterior (AP) and left–right (LR) direction. Proton beam deflection considerably reduced robustness against inter-fractional changes for the B scenario. Range agreement, gamma-index pass-rates and PTV V95% were significantly lower compared to no B . Improved robustness was obtained for minus B and B G81 , the latter showing only minor differences to no B . The magnetic field introduced slight dosimetric changes under LR shifts. The impact of AP shifts was considerably larger, and equivalent for scenarios with and without B-field. Results suggest that robustness equivalent to PT without magnetic field can be achieved by adaptation of the treatment parameters, such as B-field orientation ( minus B ) with respect to the patient and/or gantry angle ( B G81 ). MRI-guided PT for prostate cancer might thus be implemented without compromising robustness compared to state-of-the-art CT-guided PT.
- 19 October 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (21) , 8470-8482
A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer
Combining magnetic-resonance imaging (MRI) and proton therapy (PT) using pencil-beam scanning (PBS) may improve image-guided radiotherapy. We aimed at assessing the impact of a magnetic field on PBS-PT plan quality and robustness. Specifically, the robustness against anatomical changes and positioning errors in an MRI-guided scenario with a 30 cm radius 1.5 T magnetic field was studied for prostate PT. Five prostate cancer patients with three consecutive CT images ( CT1-3 ) were considered. Single-field uniform dose PBS-PT plans were generated on the segmented CT1 with Monte-Carlo-based treatment planning software for inverse optimization. Plans were optimized at 90° gantry angle without B-field ( no B ), with ±1.5 T B-field ( B and minus B ), as well as at 81° gantry angle and +1.5 T ( B G81 ). Plans were re-calculated on aligned CT2 and CT3 to study the impact of anatomical changes. Dose distributions were compared in terms of changes in DVH parameters, proton range and gamma-index pass-rates. To assess the impact of positioning errors, DVH parameters were compared for ±5 mm CT1 patient shifts in anterior–posterior (AP) and left–right (LR) direction. Proton beam deflection considerably reduced robustness against inter-fractional changes for the B scenario. Range agreement, gamma-index pass-rates and PTV V95% were significantly lower compared to no B . Improved robustness was obtained for minus B and B G81 , the latter showing only minor differences to no B . The magnetic field introduced slight dosimetric changes under LR shifts. The impact of AP shifts was considerably larger, and equivalent for scenarios with and without B-field. Results suggest that robustness equivalent to PT without magnetic field can be achieved by adaptation of the treatment parameters, such as B-field orientation ( minus B ) with respect to the patient and/or gantry angle ( B G81 ). MRI-guided PT for prostate cancer might thus be implemented without compromising robustness compared to state-of-the-art CT-guided PT.
- 16 December 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (1) , 165-185
A novel method for interactive multi-objective dose-guided patient positioning
In intensity-modulated radiation therapy (IMRT), 3D in-room imaging data is typically utilized for accurate patient alignment on the basis of anatomical landmarks. In the presence of non-rigid anatomical changes, it is often not obvious which patient position is most suitable. Thus, dose-guided patient alignment is an interesting approach to use available in-room imaging data for up-to-date dose calculation, aimed at finding the position that yields the optimal dose distribution. This contribution presents the first implementation of dose-guided patient alignment as multi-criteria optimization problem. User-defined clinical objectives are employed for setting up a multi-objective problem. Using pre-calculated dose distributions at a limited number of patient shifts and dose interpolation, a continuous space of Pareto-efficient patient shifts becomes accessible. Pareto sliders facilitate interactive browsing of the possible shifts with real-time dose display to the user. Dose interpolation accuracy is validated and the potential of multi-objective dose-guided positioning demonstrated for three head and neck (H&N) and three prostate cancer patients. Dose-guided positioning is compared to replanning for all cases. A delineated replanning CT served as surrogate for in-room imaging data. Dose interpolation accuracy was high. Using a 2 % dose difference criterion, a median pass-rate of 95.7% for H&N and 99.6% for prostate cases was determined in a comparison to exact dose calculations. For all patients, dose-guided positioning allowed to find a clinically preferable dose distribution compared to bony anatomy based alignment. For all H&N cases, mean dose to the spared parotid glands was below 26 G y (up to 27.5 G y with bony alignment) and clinical target volume (CTV) V 95 % above 99.1% (compared to 95.1%). For all prostate patients, CTV V 95 % was above 98.9% (compared to 88.5%) and V 50 G y to the rectum below 50 % (compared to 56.1%). Replanning yielded improved results for the H&N cases. For the prostate cases, differences to dose-guided positioning were minor.
- 16 December 2016
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (1) , 165-185
A novel method for interactive multi-objective dose-guided patient positioning
In intensity-modulated radiation therapy (IMRT), 3D in-room imaging data is typically utilized for accurate patient alignment on the basis of anatomical landmarks. In the presence of non-rigid anatomical changes, it is often not obvious which patient position is most suitable. Thus, dose-guided patient alignment is an interesting approach to use available in-room imaging data for up-to-date dose calculation, aimed at finding the position that yields the optimal dose distribution. This contribution presents the first implementation of dose-guided patient alignment as multi-criteria optimization problem. User-defined clinical objectives are employed for setting up a multi-objective problem. Using pre-calculated dose distributions at a limited number of patient shifts and dose interpolation, a continuous space of Pareto-efficient patient shifts becomes accessible. Pareto sliders facilitate interactive browsing of the possible shifts with real-time dose display to the user. Dose interpolation accuracy is validated and the potential of multi-objective dose-guided positioning demonstrated for three head and neck (H&N) and three prostate cancer patients. Dose-guided positioning is compared to replanning for all cases. A delineated replanning CT served as surrogate for in-room imaging data. Dose interpolation accuracy was high. Using a 2 % dose difference criterion, a median pass-rate of 95.7% for H&N and 99.6% for prostate cases was determined in a comparison to exact dose calculations. For all patients, dose-guided positioning allowed to find a clinically preferable dose distribution compared to bony anatomy based alignment. For all H&N cases, mean dose to the spared parotid glands was below 26 G y (up to 27.5 G y with bony alignment) and clinical target volume (CTV) V 95 % above 99.1% (compared to 95.1%). For all prostate patients, CTV V 95 % was above 98.9% (compared to 88.5%) and V 50 G y to the rectum below 50 % (compared to 56.1%). Replanning yielded improved results for the H&N cases. For the prostate cases, differences to dose-guided positioning were minor.
- 23 September 2016
- Published by Wiley in Medical Physics
- Vol. 43 (10) , 5635-5646
Investigating deformable image registration and scatter correction for CBCT‐based dose calculation in adaptive IMPT
Purpose: This work aims at investigating intensity corrected cone‐beam x‐ray computed tomography (CBCT) images for accurate dose calculation in adaptive intensity modulated proton therapy (IMPT) for prostate and head and neck (H&N) cancer. A deformable image registration (DIR)‐based method and a scatter correction approach using the image data obtained from DIR as prior are characterized and compared on the basis of the same clinical patient cohort for the first time.Methods: Planning CT (pCT) and daily CBCT data (reconstructed images and measured projections) of four H&N and four prostate cancer patients have been considered in this study. A previously validated Morphons algorithm was used for DIR of the planning CT to the current CBCT image, yielding a so‐called virtual CT (vCT). For the first time, this approach was translated from H&N to prostate cancer cases in the scope of proton therapy. The warped pCT images were also used as prior for scatter correction of the CBCT projections for both tumor sites. Single field uniform dose and IMPT (only for H&N cases) treatment plans have been generated with a research version of a commercial planning system. Dose calculations on vCT and scatter corrected CBCT (CBCTcor) were compared by means of the proton range and a gamma‐index analysis. For the H&N cases, an additional diagnostic replanning CT (rpCT) acquired within three days of the CBCT served as additional reference. For the prostate patients, a comprehensive contour comparison of CBCT and vCT, using a trained physician's delineation, was performed.Results: A high agreement of vCT and CBCTcor was found in terms of the proton range and gamma‐index analysis. For all patients and indications between 95% and 100% of the proton dose profiles in beam's eye view showed a range agreement of better than 3 mm. The pass rate in a (2%,2 mm) gamma‐comparison was between 96% and 100%. For H&N patients, an equivalent agreement of vCT and CBCTcor to the reference rpCT was observed. However, for the prostate cases, an insufficient accuracy of the vCT contours retrieved from DIR was found, while the CBCTcor contours showed very high agreement to the contours delineated on the raw CBCT.Conclusions: For H&N patients, no considerable differences of vCT and CBCTcor were found. For prostate cases, despite the high dosimetric agreement, the DIR yields incorrect contours, probably due to the more pronounced anatomical changes in the abdomen and the reduced soft‐tissue contrast in the CBCT. Using the vCT as prior, these inaccuracies can be overcome and images suitable for accurate delineation and dose calculation in CBCT‐based adaptive IMPT can be retrieved from scatter correction of the CBCT projections.
- 23 September 2016
- Published by Wiley in Medical Physics
- Vol. 43 (10) , 5635-5646
Investigating deformable image registration and scatter correction for CBCT‐based dose calculation in adaptive IMPT
Purpose: This work aims at investigating intensity corrected cone‐beam x‐ray computed tomography (CBCT) images for accurate dose calculation in adaptive intensity modulated proton therapy (IMPT) for prostate and head and neck (H&N) cancer. A deformable image registration (DIR)‐based method and a scatter correction approach using the image data obtained from DIR as prior are characterized and compared on the basis of the same clinical patient cohort for the first time.Methods: Planning CT (pCT) and daily CBCT data (reconstructed images and measured projections) of four H&N and four prostate cancer patients have been considered in this study. A previously validated Morphons algorithm was used for DIR of the planning CT to the current CBCT image, yielding a so‐called virtual CT (vCT). For the first time, this approach was translated from H&N to prostate cancer cases in the scope of proton therapy. The warped pCT images were also used as prior for scatter correction of the CBCT projections for both tumor sites. Single field uniform dose and IMPT (only for H&N cases) treatment plans have been generated with a research version of a commercial planning system. Dose calculations on vCT and scatter corrected CBCT (CBCTcor) were compared by means of the proton range and a gamma‐index analysis. For the H&N cases, an additional diagnostic replanning CT (rpCT) acquired within three days of the CBCT served as additional reference. For the prostate patients, a comprehensive contour comparison of CBCT and vCT, using a trained physician's delineation, was performed.Results: A high agreement of vCT and CBCTcor was found in terms of the proton range and gamma‐index analysis. For all patients and indications between 95% and 100% of the proton dose profiles in beam's eye view showed a range agreement of better than 3 mm. The pass rate in a (2%,2 mm) gamma‐comparison was between 96% and 100%. For H&N patients, an equivalent agreement of vCT and CBCTcor to the reference rpCT was observed. However, for the prostate cases, an insufficient accuracy of the vCT contours retrieved from DIR was found, while the CBCTcor contours showed very high agreement to the contours delineated on the raw CBCT.Conclusions: For H&N patients, no considerable differences of vCT and CBCTcor were found. For prostate cases, despite the high dosimetric agreement, the DIR yields incorrect contours, probably due to the more pronounced anatomical changes in the abdomen and the reduced soft‐tissue contrast in the CBCT. Using the vCT as prior, these inaccuracies can be overcome and images suitable for accurate delineation and dose calculation in CBCT‐based adaptive IMPT can be retrieved from scatter correction of the CBCT projections.
- 28 January 2016
- Published by Wiley in Medical Physics
- Vol. 43 (2) , 975-982
Initial clinical evaluation of PET‐based ion beam therapy monitoring under consideration of organ motion
Purpose: Intrafractional organ motion imposes considerable challenges to scanned ion beam therapy and demands for a thorough verification of the applied treatment. At the Heidelberg Ion‐Beam Therapy Center (HIT), the scanned ion beam delivery is verified by means of postirradiation positron‐emission‐tomography (PET) imaging. This work presents a first clinical evaluation of PET‐based treatment monitoring in ion beam therapy under consideration of target motion.Methods: Three patients with mobile liver lesions underwent scanned carbon ion irradiation at HIT and postirradiation PET/CT (x‐ray‐computed‐tomography) imaging with a commercial scanner. Respiratory motion was recorded during irradiation and subsequent image acquisition. This enabled a time‐resolved (4D) calculation of the expected irradiation‐induced activity pattern and, for one patient where an additional 4D CT was acquired at the PET/CT scanner after treatment, a motion‐compensated PET image reconstruction. For the other patients, PET data were reconstructed statically. To verify the treatment, calculated prediction and reconstructed measurement were compared with a focus on the ion beam range.Results: Results in the current three patients suggest that for motion amplitudes in the order of 2 mm there is no benefit from incorporating respiratory motion information into PET‐based treatment monitoring. For a target motion in the order of 10 mm, motion‐related effects become more severe and a time‐resolved modeling of the expected activity distribution can lead to an improved data interpretation if a sufficient number of true coincidences is detected. Benefits from motion‐compensated PET image reconstruction could not be shown conclusively at the current stage.Conclusions: The feasibility of clinical PET‐based treatment verification under consideration of organ motion has been shown for the first time. Improvements in noise‐robust 4D PET image reconstruction are deemed necessary to enhance the clinical potential.
- 28 January 2016
- Published by Wiley in Medical Physics
- Vol. 43 (2) , 975-982
Initial clinical evaluation of PET‐based ion beam therapy monitoring under consideration of organ motion
Purpose: Intrafractional organ motion imposes considerable challenges to scanned ion beam therapy and demands for a thorough verification of the applied treatment. At the Heidelberg Ion‐Beam Therapy Center (HIT), the scanned ion beam delivery is verified by means of postirradiation positron‐emission‐tomography (PET) imaging. This work presents a first clinical evaluation of PET‐based treatment monitoring in ion beam therapy under consideration of target motion.Methods: Three patients with mobile liver lesions underwent scanned carbon ion irradiation at HIT and postirradiation PET/CT (x‐ray‐computed‐tomography) imaging with a commercial scanner. Respiratory motion was recorded during irradiation and subsequent image acquisition. This enabled a time‐resolved (4D) calculation of the expected irradiation‐induced activity pattern and, for one patient where an additional 4D CT was acquired at the PET/CT scanner after treatment, a motion‐compensated PET image reconstruction. For the other patients, PET data were reconstructed statically. To verify the treatment, calculated prediction and reconstructed measurement were compared with a focus on the ion beam range.Results: Results in the current three patients suggest that for motion amplitudes in the order of 2 mm there is no benefit from incorporating respiratory motion information into PET‐based treatment monitoring. For a target motion in the order of 10 mm, motion‐related effects become more severe and a time‐resolved modeling of the expected activity distribution can lead to an improved data interpretation if a sufficient number of true coincidences is detected. Benefits from motion‐compensated PET image reconstruction could not be shown conclusively at the current stage.Conclusions: The feasibility of clinical PET‐based treatment verification under consideration of organ motion has been shown for the first time. Improvements in noise‐robust 4D PET image reconstruction are deemed necessary to enhance the clinical potential.